UsAgainstAlzheimer's Blog

Stay up to date on the latest from UsAgainstAlzheimer's on our blog. Read about what our team is working on, the latest advancements in research, and what you can do to join the fight.

Thumbnail
August 26, 2019 - Lynda Everman

Growing Our Voices: Let’s Talk About Dementia

1994: President Ronald Reagan penned his now famous letter to the American public announcing that he was in the early stages of Alzheimer’s disease. The same year, m y dad , at 81, had just been diagnosed with “memory problems”; my son Mike was a sophomore in high school; and I was three years into a new marriage and at the top of my Human Resources career. Three years later my husband Richard, at 57, was diagnosed with Mild C ognitive I mpairment . Dad died in 2001 from what I later learned was vascular dementia and Richard in 2012
Thumbnail
August 07, 2019 - UsAgainstAlzheimer's

“A Devil of a Disease”: The Current Alzheimer’s Pipeline

This article was originally published by BioSpace on August 7, 2019. By Mark Terry As anyone following Alzheimer’s research knows, drug development for the disease has been a wasteland of failed clinical trials with literally billions of dollars thrown at drugs that have proved ineffective at preventing or halting the disease. In March 2019, in what many felt was a turning point for the industry, Cambridge, Massachusetts-based Biogen and its collaboration partner, Tokyo-based Eisai, announced they were discontinuing the global Phase III clinical trials, ENGAGE and EMERGE, of aducanumab in patients with mild cognitive impairment from Alzheimer’s and mild Alzheimer’s
Thumbnail
July 25, 2019 - Andres Martin

My Birthday Wish

My name is Andres Martin and this week I turned 32 years old. I’m a proud father, husband, and veteran. Over the last couple of years, I’ve come to recognize how precious my birthdays are. My military service has taught me this, the birth of my daughter has taught me this, and my genes have taught me this. You see my family is from a region in Mexico that is host to the “Jalisco mutation,” a mutation which guarantees carriers will develop early-onset Alzheimer’s, and one for which I recently tested positive. My diagnosis answered a lot of questions. It
July 17, 2019 - UsAgainstAlzheimer's

Welcome to the New Era of Alzheimer’s Research: How People with Alzheimer’s and Care Partners are Shaping the Future of Drug Development

This article was originally published by Lundbeck on July 17, 2019. By Mark Terry Leigh Callahan, PhD, is a respected epidemiologist and outcomes researcher who focuses on rheumatic disease. Her husband, John Winfield, MD, now retired, had a distinguished career as a researcher and rheumatologist. While their professional lives have focused principally on joints, they now find themselves at the leading edge of brain research. This is because John has Alzheimer’s, Leigh is his care partner, and together they are participating in a groundbreaking research project that seeks to generate patient/care partner insights and develop new meaningful, measurable outcomes that
Thumbnail
July 23, 2019 - George Vradenburg

Brain Health Redux

UsAgainstAlzheimer’s continues urgent call for a new approach to brain health across the lifespan